Biomerica, Inc. (BMRA) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Track Biomerica, Inc. (BMRA) stock performance with short-term forecasts for 2025 and long-term BMRA price prediction till 2050. Review historical trends, get analyst Buy/Sell/Hold ratings, and stay updated with the latest Biomerica, Inc. headlines.
1 Month Prediction
$1.39 [117.04%]
3 Month Prediction
$1.00 [56.25%]
6 Month Prediction
$1.00 [56.25%]
1 Year Prediction
$1.00 [56.25%]
3 Year Prediction
$1.00 [56.25%]
5 Year Prediction
$1.00 [56.25%]
About Biomerica, Inc.
Biomerica, Inc., founded in September 1971, is a biomedical technology company headquartered in Irvine, California. The company develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases around the world. Their primary focus is on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. They have a portfolio of over 80 diagnostic products and more than 100 patents related to its innovations.
Also, Biomerica is developing InFoods IBS, a product that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms. And, the company is working on hp+detect, an H. pylori diagnostic test that indicates if a patient is infected with the H. pylori bacteria.
The company operates two manufacturing facilities: one located in Irvine, California, and another in Mexicali, Mexico. Both facilities are certified under ISO 13485 and registered with the FDA.
Biomerica, Inc. (BMRA) Historical Performance
Change
Since inception, BMRA has decreased by 90.52%. In the last 5 years, BMRA has fallen from $2.80 to $0.64, a massive -77.14% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $9.11 and a low of $0.30.
52 Week Range
$0.24
$1.35
The current price $0.64 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
BMRA Stock Price History
Based on BMRA stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the BMRA stock has fallen from $2.8 - $9.11 to $0.64 - $0.64, which is down -77.35%. Currently, the stock follows downward trend.
Here, we have calculated stock range of BMRA, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $2.8 - $9.11 | $6.24 | 120.85 | 1 Year Change |
| 2021 | $3.65 - $6.8 | $4.73 | 67.41 | 2 Year Change |
| 2022 | $2.77 - $4.47 | $3.65 | 29.18 | 3 Year Change |
| 2023 | $0.86 - $3.0 | $1.52 | -46.2 | 4 Year Change |
| 2024 | $0.3 - $1.22 | $0.56 | -80.18 | 5 Year Change |
| 2025 | $0.64 - $0.64 | $0.64 | -77.35 | 6 Year Change |
BMRA Price Performance
6-Month Performance
BMRA stock jumped by 45.45% in the last six months.
1-Year Performance
The stock has trended downwards by 47.54% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 85.25%.
5-Year Performance
In the last 5 years, the stock has gone down by 77.14%.
According to Biomerica, Inc.'s historical data, below graph gives us the exact picture of how the BMRA stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 1 year and a decline in 4 years.
2020
64.90% ↑
2021
21.89% ↓
2022
13.88% ↓
2023
62.69% ↓
2024
76.00% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Biomerica, Inc. (BMRA) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $1.64 M (Q4)
Revenue for Q4 ending 30th November, 2024 decreased 9.46% compared to Q3 ending 31st August, 2024.
Annual Revenue: $5.58 M (1Y)
Revenue for trailing 12 months increased 2.97% year over year from 31st May, 2024.
Market Capitalization
Biomerica, Inc. has a market capitalization of $10.77M, which places BMRA in the nano-cap category.
Fundamental Analysis
EPS: $-0.06 (Q4), $-0.36 (1Y)
EPS decreased 25.00% since last quarter, and decreased 28.00% since last year.
Net Income: $-950.00 T (Q4), $-5.98 M (1Y)
Net Income decreased 27.81% since last quarter, and decreased 16.27% since last year.
Free Cash Flow: $-824.00 T (Q4), $-5.48 M (1Y)
Free Cash Flow decreased 38.69% since last quarter, and decreased 1.37% since last year.
Net Profit Margin: -58.07% (Q4), -107.21% (1Y)
Net Profit Margin decreased 20.27% since last quarter, and decreased 18.69% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for BMRA stock. These indicators help you understand Biomerica, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for BMRA stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $0.35 |
| SMA50 | $0.34 |
| SMA200 | $0.43 |
| RSI | 74.60 |
| Beta | -1.14 |
SMA20 < Current Price
This signals BMRA stock is in short-term bullish momentum.
SMA50 < Current Price
This signals BMRA stock is in mid-term bullish momentum.
SMA200 < Current Price
This signals BMRA stock is in long-term bullish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for BMRA stock is Neutral. Out of all indicators, 4 indicates bullish signals, 4 signals bearish trends and 1 gives neutral trends. The BMRA stock forecast was last updated on 17 January, 2025.
Biomerica, Inc. (BMRA) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $1.00 by the end of 2025, and can reach around $0.54 to $0.75 in 2026. And, the long-term forecast suggests that the stock may further jump to $1.24 - $1.30 in 2028, and $1.01 - $1.06 by 2031. So, the BMRA stock shows a strong upward trend in the next several years.
Short-term BMRA Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-02 | $1.39 | 117.19% |
| 2025-03 | $1.00 | 56.25% |
| 2025-04 | $1.00 | 56.25% |
| 2025-05 | $1.00 | 56.25% |
| 2025-06 | $1.00 | 56.25% |
| 2025-07 | $1.00 | 56.25% |
| 2025-08 | $1.00 | 56.25% |
| 2025-09 | $1.00 | 56.25% |
| 2025-10 | $1.00 | 56.25% |
| 2025-11 | $1.00 | 56.25% |
| 2025-12 | $1.00 | 56.25% |
In 2025, the BMRA stock price is expected to fluctuate between $1.0 and $1.39. According to the monthly forecast, the stock could rise to $1.00 by December 2024. If compared to the BMRA's current price, the stock could gain 56.25% by the end of this year.
Long-term BMRA Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $0.54 | $0.82 | $0.75 | 17.19% |
| 2027 | $1.22 | $1.08 | $0.62 | -3.12% |
| 2028 | $1.24 | $0.92 | $1.30 | 103.13% |
| 2029 | $1.01 | $0.94 | $1.33 | 107.81% |
| 2030 | $1.63 | $0.56 | $0.84 | 31.25% |
| 2031 | $1.01 | $0.97 | $1.06 | 65.63% |
| 2032 | $0.95 | $1.22 | $0.59 | -7.81% |
| 2033 | $1.12 | $1.02 | $0.73 | 14.06% |
| 2034 | $1.25 | $1.23 | $0.89 | 39.06% |
| 2035 | $1.40 | $1.03 | $0.79 | 23.44% |
| 2036 | $0.29 | $1.37 | $0.90 | 40.63% |
| 2037 | $1.29 | $1.49 | $1.20 | 87.5% |
| 2038 | $0.96 | $0.99 | $0.62 | -3.12% |
| 2039 | $1.56 | $1.36 | $1.35 | 110.94% |
| 2040 | $0.96 | $0.67 | $1.18 | 84.38% |
| 2041 | $0.87 | $1.19 | $0.89 | 39.06% |
| 2042 | $0.75 | $1.51 | $1.24 | 93.75% |
| 2043 | $0.69 | $0.85 | $1.01 | 57.81% |
| 2044 | $1.01 | $1.26 | $0.99 | 54.69% |
| 2045 | $0.74 | $0.54 | $0.71 | 10.94% |
| 2046 | $0.98 | $1.39 | $1.10 | 71.88% |
| 2047 | $0.61 | $0.71 | $1.16 | 81.25% |
| 2048 | $1.57 | $1.28 | $1.40 | 118.75% |
| 2049 | $0.90 | $1.57 | $0.93 | 45.31% |
| 2050 | $1.07 | $1.45 | $0.76 | 18.75% |
| 2051 | $1.06 | $0.64 | $1.20 | 87.5% |
Biomerica, Inc. (BMRA) Stock Price Prediction & Forecast 2025
At the start of 2025, the BMRA stock was at $0.64. Today, it is trading at $0.64, which is 0.00% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $1.00 by December 2025 with a 56.25% change.
Biomerica, Inc. (BMRA) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant appreciation in the BMRA stock. During this period, the BMRA's price is forecasted to shift from $0.54 to $0.84, which is 55.56% gain.
In 2026, the stock would possibly open at $0.54, escalates to $0.82 by mid-year, and wraps up at $0.75, reflecting a 17.31% increase from today's price. Further moving to 2030, the stock can kick off the year at $1.63, soar to $0.56 by mid-year, and finish at $0.84, which is 31.41% change from current price.
Biomerica, Inc. (BMRA) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $1.01 to $1.18, which is up 66.23%
In 2031, we can expect BMRA to fluctuate between $1.01 and $1.06, a shift indicating a 66.23% gain by year-end compared to current price. And Until 2040, BMRA can likely vary from $0.96 to $1.18. By the end of 2040, the stock could record a 85.09% rise from today's stock price.
Biomerica, Inc. (BMRA) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the BMRA stock can see an a downturn from $0.87 to $0.76 in this period. In 2041, the stock can experience a high of $1.19 by mid-year, closing the year at $0.89. This results in a 85.65% increase from today.
Moving towards the end of 2050, BMRA is projected to open the year at $1.07. The stock may peak to $1.45 during mid-year and finish the year at $0.76. Compared to the stock's current price, this translates to an overall gain of 19.47% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
BMRA Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| INBS | Intelligent Bio Solutions Inc. | - | $1.33 | -5.00% ▼ | -24.81 ▼ |
| SENS | Senseonics Holdings, Inc. | - | $0.78 | 48.64% ▲ | $28.63 ▲ |
| PACB | Pacific Biosciences of California, Inc. | - | $2.10 | 0.00% ▼ | -52.38 ▼ |
Last updated Jan 17 at 9:47 PM
BMRA : Buy, Sell Or Hold?
Analyst Ratings
No analyst ratings available for this stock.
Expert Analysis
According to BMRA short-term and long-term forecast, Biomerica, Inc. shares are projected to go up by 18.75%, and reach a value of $0.76 per share by 2050.
As per technical analysis, indicators show a Neutral sentiment, while Fear & Greed Index stands at 42.857142857142854, which signals Fear. Also, BMRA has recorded 8/30 green days, which reflects a 40.0% positivity rate with a price volatility of 0.20%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that BMRA stock is undervalued. So, Based on BMRA prediction and analysis, it may be the best time to hold BMRA stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "BMRA” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.
